Astra Expects U.S. Trial Update Within Two Weeks, Analyst Says

(Bloomberg) -- AstraZeneca Plc told analysts it expects an update in the next one to two weeks on its halted U.S. trial evaluating the coronavirus vaccine under development with the University of O...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.